• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: February 22-26, 2010

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

 

February 22-26, 2010

FDA Official and Title

Date

Location

Other FDA Participants

Non-FDA Participants

Subject

Margaret A. Hamburg, M.D., Commissioner of Food and Drugs2/24/10Bethesda, MDJoshua Sharfstein, Jesse GoodmanKathleen Sebelius, Dora Hughes, Jenny Backus (Health and Human Services); Francis Collins (National Institutes of Health)FDA-National Institutes of Health Leadership Council
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs2/25/10Washington, DCPeper Long, George Strait, Molly MuldoonEdwards Abrahams (Personalized Medicine Coalition); Ralph Snyderman (Duke University)Speech at Personalized Medicine Coalition 6th Annual Luncheon
Joshua M. Sharfstein, M.D., Principal Deputy Commissioner of Food and Drugs2/22/10-
2/26/10
N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine2/25/10TeleconferenceMerton Smith, William Flynn, Tracey Forfa, Martine Hartogensis, Meg Oeller, Steve Vaughn, Brandi Robinson, Jon Scheid, Dave White, Kevin Greenlees, Ana Hernandez, Linda Tollefson, Mike OehlsenDavid Mackay, Kornelia Grein, Isaura Duarte, Jill Kieffer, Loredana Locatelli, Jordi Torren Edo, Hilde Boone, Emer Cook (European Medicines Agency)European Medicines Agency Quarterly Meeting
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine2/25/10Rockville, MDWilliam Flynn, Diane Heinz, Jeff Punderson, LeeAnne PalmerNora Pihkala (United States Department of Agriculture)Meet and Greet
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget2/22/10-
2/26/10
N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/23/10-
2/24/10
Austin, TXLawrence Lesko,  Shiew Mei Huang, Steven Kozlowski, Mwango Kashoki Kathleen Jaeger (Generic Pharmaceutical Association); Ganesh Yenkataraman (Momenta Pharmaceuticals, Inc.);  Andreas Seiter (The World Bank); Geoffrey Levitt (Pfizer)International Conference on Drug Development 
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research2/26/10Rockville, MDN/AEric Rowinsky (Champions Biotechnology); Stephen Little (Personalized Healthcare, QIAGEN); Christopher Wasden (Pricewaterhouse Coopers)MdBio Breakfast Series Center for Advanced Research in Biotechnology 
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/22/10Silver Spring, MDSusan Gardner, Tim Ulatowski, Jonathan Sackner-Bernstein, Cathy NorcioTim Ring, John Weiland, Gary Dolch, Sr., Patricia Christian (C.R. Bard)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/23/10Silver Spring, MDSusan Gardner, Matthew Hilebrenner, David Buckles, Gladys Rodriquez, Kimber Richter, Cathy NorcioMike Mussallem, Dirksen Lehman (Edwards Lifesciences)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/24/10Silver Spring, MDMaggie Dietrich, Jonathan Sackner-BernsteinKelly Sloane (National Venture Capital Association)Medical Devices
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health2/26/10Silver Spring, MDNancy Stade, Cathy NorcioEd Basile, D. Cameron Findlay, Sandra Kalter (Medtronic)Medical Devices
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health2/22/10Bethesda, MDSeveral FDA Officials and Staff MembersSeveral participants involved in public health advocacy, including, but not limited to, government and academiaPresentation at the Science Board Meeting
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health2/23/10-
2/24/10
Washington, DCSeveral FDA Officials and Staff MembersSeveral participants from private industry, government, and academiaKeynote Presentation at the Institute of Medicine Workshop on Countermeasure Enterprise
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health2/25/10Washington, DCN/ASeveral participants from private industry, government, Congress, and academiaSpeech at President's Council of Advisors on Science and Technology Workshop on Influenza Vaccinology
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs2/22/10-
2/26/10
N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Acting Director, Center for Biologics Evaluation and Research2/22/10-
2/26/10
N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products2/23/10Rockville, MDSeveral FDA Staff MembersRon Borland (Cancer Council Victoria)Tobacco Control in Australia
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products2/25/10Baltimore, MDN/ASeveral participants from private industry, government, and academiaKeynote Speech at Society for Research on Nicotine and Tobacco Annual Conference
Michael Chappell, Acting Associate Commissioner for Regulatory Affairs2/22/10-
2/26/10
N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods2/25/10Ottawa, CanadaStephen Sundlof, Mary Lou Valdez, Camille Brewer, Matthew Eckel, Holly Hall, Daniel McChesneyCarole Swan, Sandra Wing, Cameron Prince, Martine Dubuc, George Shaw, Paul Mayers, Barbara Jordan, Karen McIntyre, Mary Ann Gree, Debra Bryanton, Reem Barakat, Andrew Dawson (Canadian Food Inspection Agency); Meena Ballantyne, Samuel Godefroy, Beth Junkins, Lucie Olson, Bindu Islam (Health Canada) Canadian Food Inspection Agency/FDA Food Safety Committee Meeting
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs2/22/10-
2/24/10
San Francisco, CASandra Kweder, Timothy Cote, Robert Lionberger, Ping ZhaoSeveral participants from foreign government counterparts, regulated industry, and academiaUCSF's American Course on Drug Development and Regulatory Sciences:  Global Registration and Approval Process
Ralph Tyler, J.D., Chief Counsel2/25/10Silver Spring, MDN/AD. Cameron Findlay, Sandra Kalter (Medtronic); Edward Basile (King & Spalding)Courtesy Visit
Russell Abbott, Deputy Commissioner for Administration2/22/10-
2/26/10
N/AN/AN/ANo Significant Meetings
Stephen Sundlof, D.V.M., Ph.D., Director, Center for Food Safety and Applied Nutrition2/23/10Washington, DCN/AN/ANational Advisory Committee on Microbiological Criteria for Foods Executive Committee Meeting
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research2/25/10-
2/26/10
Washington, DCN/AN/ANational Academies of Science Standing Committee on Use of Emerging Science for Environmental Health Decisions - Government Liaison Group